e-Article
EORTC 1707 VESTIGE: Adjuvant immunotherapy in patients (pts) with resected Gastroesophageal Adenocarcinoma (GEA) following preoperative chemotherapy with high risk for recurrence (ypN+ and/or R1)
Document Type
Journal
Author
Lordick, F.; Mauer, M.; Stocker, G.; Cella, C. A.; Ben-Aharon, I.; Piessen, G.; Wyrwicz, L.; Al-Haidari, G.; Fleitas-Kanonnikov, T.; Boige, V.; Obermannova, R.; Stahl, M.; Martens, U.; Gomez-Martin, C.; Thuss-Patience, P.; Arrazubi, V.; Avallone, A.; Shiu, K. -K.; Lorenzen, S.; Daum, S.; Sinn, M.; Giraut, A.; Smyth, E.
Source
Subject
Language
English
ISSN
22965262